CT1192
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CT1192, covering 2025-06-24 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE [Phase 1]